U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling 
One Percent Rule Checklist For Safer Forex Trading Risk 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
PLEASANTON, Calif., April 12, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that the Company will release its 2017 first quarter financial results before the market opens on Wednesday, April 26th. Natus management will host an investment-community conference call the same day beginning at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss those results and to answer questions.
Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 2514858. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 42514858.
The conference call also will be available real-time via the Internet at http://investor.natus.com and a recording of the call will be available on the Company's Web site for 90 days following the completion of the call.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT: Natus Medical Incorporated Jonathan A. Kennedy Executive Vice President and Chief Financial Officer (925) 223-6700 [email protected]
